Leo Fondet 2022 AR2
The report outlines the LEO Foundation's activities and financial performance for 2022, a year of transition across its ownership, philanthropic, and investment areas. As the controlling owner of LEO Pharma, the Foundation supported the company's growth strategy, pipeline advancement, and organizational simplification, including the global launch of tralokinumab. Philanthropically, the Foundation awarded DKK 125 million across 36 grants to support independent skin research. Despite a challenging macroeconomic environment resulting in a negative 9% return on its financial investments, the Foundation continued to integrate ESG screening across all listed mandates and developed a new Code of Conduct.
Company: Leo Fondet
Sector: Finance & insurance
Country: Denmark
Year: 2022
Type: AR2
Pages: 89
Back to company
Leo Fondet
Annual Report
The report outlines the LEO Foundation's activities and financial performance for 2022, a year of transition across its ownership, philanthropic, and investment areas. As the controlling owner of LEO Pharma, the Foundation supported the company's growth strategy, pipeline advancement, and organizational simplification, including the global launch of tralokinumab. Philanthropically, the Foundation awarded DKK 125 million across 36 grants to support independent skin research. Despite a challenging macroeconomic environment resulting in a negative 9% return on its financial investments, the Foundation continued to integrate ESG screening across all listed mandates and developed a new Code of Conduct.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees